» Articles » PMID: 18482055

Simple, Defensible Sample Sizes Based on Cost Efficiency

Overview
Journal Biometrics
Specialty Public Health
Date 2008 May 17
PMID 18482055
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

The conventional approach of choosing sample size to provide 80% or greater power ignores the cost implications of different sample size choices. Costs, however, are often impossible for investigators and funders to ignore in actual practice. Here, we propose and justify a new approach for choosing sample size based on cost efficiency, the ratio of a study's projected scientific and/or practical value to its total cost. By showing that a study's projected value exhibits diminishing marginal returns as a function of increasing sample size for a wide variety of definitions of study value, we are able to develop two simple choices that can be defended as more cost efficient than any larger sample size. The first is to choose the sample size that minimizes the average cost per subject. The second is to choose sample size to minimize total cost divided by the square root of sample size. This latter method is theoretically more justifiable for innovative studies, but also performs reasonably well and has some justification in other cases. For example, if projected study value is assumed to be proportional to power at a specific alternative and total cost is a linear function of sample size, then this approach is guaranteed either to produce more than 90% power or to be more cost efficient than any sample size that does. These methods are easy to implement, based on reliable inputs, and well justified, so they should be regarded as acceptable alternatives to current conventional approaches.

Citing Articles

Methyl-donor supplementation in women with systemic lupus erythematosus with different nutritional status: the protocol for a randomised, double-blind, placebo-controlled trial.

da Mota J, Carvalho L, Ribeiro A, Souza L, Borba E, Roschel H Lupus Sci Med. 2024; 11(2).

PMID: 39375179 PMC: 11459299. DOI: 10.1136/lupus-2024-001279.


Effects of a lifestyle intervention on cardiovascular risk factors in systemic lupus erythematosus patients: The study "Living well with lupus".

Mendes Sieczkowska S, Caruso Mazzolani B, Infante Smaira F, Romero M, Pasoto S, de Sa Pinto A Clin Rheumatol. 2024; 43(3):1003-1013.

PMID: 38280124 DOI: 10.1007/s10067-024-06870-2.


A randomized controlled trial of an intervention promoting physical activity and healthy eating recommendations in systemic lupus erythematosus: the protocol study "Living Well with Lupus".

Mendes Sieczkowska S, Infante Smaira F, Caruso Mazzolani B, Romero M, Pasoto S, de Sa Pinto A Rheumatol Int. 2023; 43(10):1799-1810.

PMID: 37354245 DOI: 10.1007/s00296-023-05370-x.


Food consumption based on processing level (according to Nova system) during the COVID-19 pandemic among adolescents with immunocompromised conditions: a case-control study.

Esteves G, Caruso Mazzolani B, Infante Smaira F, C Santo Andre H, Iraha A, Astley C Front Nutr. 2023; 10:1141845.

PMID: 37260519 PMC: 10227604. DOI: 10.3389/fnut.2023.1141845.


The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regression.

Tepper S, Cirillo J, Kim E, LItalien G, Tweedie J, Lodaya K J Headache Pain. 2023; 24(1):54.

PMID: 37193973 PMC: 10189936. DOI: 10.1186/s10194-023-01587-0.


References
1.
Freedman B . Equipoise and the ethics of clinical research. N Engl J Med. 1987; 317(3):141-5. DOI: 10.1056/NEJM198707163170304. View

2.
Detsky A . Using cost-effectiveness analysis to improve the efficiency of allocating funds to clinical trials. Stat Med. 1990; 9(1-2):173-84. DOI: 10.1002/sim.4780090124. View

3.
Bacchetti P, Wolf L, Segal M, McCulloch C . Ethics and sample size. Am J Epidemiol. 2005; 161(2):105-10. DOI: 10.1093/aje/kwi014. View

4.
Yokota F, Thompson K . Value of information analysis in environmental health risk management decisions: past, present, and future. Risk Anal. 2004; 24(3):635-50. DOI: 10.1111/j.0272-4332.2004.00464.x. View

5.
Tan S, Smith A . Exploratory thoughts on clinical trials with utilities. Stat Med. 1999; 17(23):2771-91. DOI: 10.1002/(sici)1097-0258(19981215)17:23<2771::aid-sim42>3.0.co;2-9. View